Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer

Withdrawn before enrolling

Conditions studied: Peripheral Neuropathy

In brief

The purpose of this study is to investigate the effect of the ReBuilder in the treatment of individuals with breast cancer and chemotherapy induced peripheral neuropathy.

Key facts

Study ID

NCT02606110

Run by

Eastern Regional Medical Center

People needed

0

Starts

2014-06-01

Last updated by the study team

2017-07-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with breast cancer referred to Physical Therapy for CIPN
• Physical Therapy Examination indicates use of Rebuilder for CIPN
• At least 18 years of age
• Signed informed consent for study population
• Willingness to complete study according to protocol

You may not qualify if…

• Patients who do not have CIPN
• Patients <18 years of age
• Inability to or unwilling to sign informed consent
• Unable to read and understand the English language
• Preexisting sensory peripheral neuropathy from other comorbid conditions such as diabetes or alcoholism
• More than three (3) prior ReBuilder treatments; OR ReBuilder within the last 30 days, for sensory peripheral neuropathy

Where it is running

• Eastern Regional Medical Center — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.